178 related articles for article (PubMed ID: 35362543)
1. Copy number alterations and epithelial‑mesenchymal transition genes in diffuse and intestinal gastric cancers in Mexican patients.
Larios-Serrato V; Martínez-Ezquerro JD; Valdez-Salazar HA; Torres J; Camorlinga-Ponce M; Piña-Sánchez P; Ruiz-Tachiquín ME
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35362543
[TBL] [Abstract][Full Text] [Related]
2. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.
Wu CM; Lee YS; Wang TH; Lee LY; Kong WH; Chen ES; Wei ML; Liang Y; Hwang TL
Oncol Rep; 2006 Jan; 15(1):57-64. PubMed ID: 16328034
[TBL] [Abstract][Full Text] [Related]
3. High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile.
Rohan P; Dos Santos EC; Abdelhay E; Binato R
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254918
[TBL] [Abstract][Full Text] [Related]
4. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
[TBL] [Abstract][Full Text] [Related]
5. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
Choi JH; Kim YB; Ahn JM; Kim MJ; Bae WJ; Han SU; Woo HG; Lee D
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622765
[TBL] [Abstract][Full Text] [Related]
6. Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition.
Tanabe S; Aoyagi K; Yokozaki H; Sasaki H
Int J Oncol; 2014 Jun; 44(6):1955-70. PubMed ID: 24728500
[TBL] [Abstract][Full Text] [Related]
7. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
[TBL] [Abstract][Full Text] [Related]
8. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z
Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
10. Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis.
Guo R; Chu A; Gong Y
J Transl Med; 2020 Nov; 18(1):418. PubMed ID: 33160391
[TBL] [Abstract][Full Text] [Related]
11. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
12. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
[TBL] [Abstract][Full Text] [Related]
15. RORβ suppresses the stemness of gastric cancer cells by downregulating the activity of the Wnt signaling pathway.
Wen Z; Chen M; Guo W; Guo K; Du P; Fang Y; Gao M; Wang Q
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278502
[TBL] [Abstract][Full Text] [Related]
16. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
17. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
18. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-205 suppresses the invasion and epithelial-mesenchymal transition of human gastric cancer cells.
Xu C; Li M; Zhang L; Bi Y; Wang P; Li J; Jiang X
Mol Med Rep; 2016 Jun; 13(6):4767-73. PubMed ID: 27082508
[TBL] [Abstract][Full Text] [Related]
20. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
